South Africa Rolls Out Twice-Yearly HIV Prevention Shot

South Africa just took a giant leap forward in the fight against HIV with a prevention shot so effective it was named Science magazine's 2024 breakthrough of the year.

Starting June 5, 2026, public clinics across the country will offer lenacapavir, an injection that protects against HIV for six months at a time. Clinical trials showed the shot was nearly 100% effective at preventing infection.

The timing couldn't be more critical. Despite enormous progress since the darkest days of South Africa's HIV epidemic, the virus still claims over 50,000 lives each year. More than 140,000 people contract HIV annually, a number that has remained stubbornly high.

For years, people at risk of HIV have had daily prevention pills available, but many struggle with the routine. Taking a pill every day is hard for anyone, and for some, the stigma of being seen with HIV medications adds another barrier. Only a few hundred thousand people in South Africa currently use the daily prevention tablets.

The new injection changes everything about convenience. Instead of remembering a pill 365 days a year, people need just two shots annually. The medication, injected just under the skin in the stomach area, slowly releases protection over six months.

What makes this rollout even more remarkable is who can access it. Clinical trials specifically included pregnant women and teenagers aged 16 and 17, groups often left out of HIV research. The injection proved safe for both populations, meaning South Africa can offer it to those who need it most.

The shot does come with minor side effects. Most people experience some pain at the injection site and possibly a small, harmless lump under the skin that typically shrinks with future doses. A skin rash can occur but usually fades quickly.

Before receiving their first injection, people will get an HIV test to confirm they don't already have the virus. This step is crucial because treating an existing HIV infection with lenacapavir alone could lead to drug resistance.

The Ripple Effect

This breakthrough represents more than just medical innovation. It's about meeting people where they are and removing barriers to protection. When prevention becomes this simple, more people can shield themselves from HIV without daily reminders or visible medications.

The rollout also signals hope for the roughly eight million South Africans living with HIV. As new infections drop, resources can focus more on treatment, creating a positive cycle that could finally turn the tide on the epidemic.

South Africa's commitment to making this cutting-edge prevention available through public clinics means the people who need it most will actually be able to get it.

With two shots a year, South Africa is writing a new chapter in its long battle against HIV, one injection at a time.